Fu-Shan Xue | Clinical Medicine | Outstanding Scientist Award

Posted on by Pencis

Prof. Fu-Shan Xue | Clinical Medicine | Outstanding Scientist Award

Fuzhou University Affiliated Provincial Hospital | China

Author Profile

Scopus

Orcid ID

🎓 THE REMARKABLE JOURNEY OF FU-SHAN XUE: A TRAILBLAZER IN ANESTHESIOLOGY

🎓 EARLY ACADEMIC PURSUITS

Fu-Shan Xue’s academic journey laid a strong foundation for his outstanding future career. His deep passion for medical sciences, particularly anesthesiology and surgery, led him to pursue rigorous academic training, culminating in his appointment as a Doctoral Supervisor. His dedication during his formative academic years built the groundwork for his later roles as a Chief Physician and Distinguished Professor at Beijing Anzhen Hospital, Capital Medical University.

🏥 PROFESSIONAL ENDEAVORS

Dr. Xue’s professional career is marked by exceptional achievements and prestigious appointments. Serving as the Chief Physician and Professor at the Anesthesiology and Surgery Center of Beijing Anzhen Hospital, he became one of the leading figures in the field. Beyond his hospital responsibilities, he has been recognized as:

  • National Candidate of the "New Century Millions of Talents Project",

  • Expert with Special Allowance of the State Council,

  • Young and Middle-Aged Expert with Outstanding National Contributions,

  • Leading Talent of the National "Ten-Thousand Talents Program".

These distinctions reflect his national and international stature as a pioneering anesthesiologist.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON CLINICAL MEDICINE

Dr. Xue has significantly advanced the field of anesthesiology through his extensive research and innovation. His focus spans various critical areas, including:

  • Innovative techniques in anesthesia and perioperative medicine,

  • Enhancing patient safety during surgical procedures,

  • Developing new surgical and anesthetic methodologies.

His contributions have led to real-world advancements in clinical practices, making surgeries safer and improving patient outcomes.

🌍 IMPACT AND INFLUENCE

The impact of Dr. Xue’s work extends far beyond the walls of his institution:

  • Published more than 1,180 academic papers, including over 830 as the first and corresponding author in SCI-indexed journals,

  • Edited and translated 15 professional books that serve as key references in the field,

  • Achieved 86 national patents (including 11 invention patents) and 10 foreign patents,

  • Honored with 8 prestigious awards at the provincial and ministerial levels.

Dr. Xue’s influence resonates through medical education, research innovation, and clinical excellence in China and globally.

📈 ACADEMIC CITATIONS

Given his prolific research output, Dr. Xue’s work has been widely cited across national and international medical communities. His extensive citation record demonstrates the foundational importance of his research in advancing anesthesiology and surgery disciplines. He stands as a major reference point for upcoming anesthesiologists and researchers worldwide.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Fu-Shan Xue’s legacy is already deeply entrenched in the history of anesthesiology:

  • A pioneer in bridging clinical practice and innovative research,

  • A mentor to new generations of physicians and researchers,

  • An architect of safer and more effective anesthesia practices.

Looking ahead, Dr. Xue continues to drive cutting-edge innovations, pursue international collaborations, and mentor young talents. His future contributions are expected to further revolutionize perioperative medicine, enhance global surgical standards, and inspire countless young professionals to follow in his footsteps.

🏅 AWARDS AND HONORS

  • China Distinguished Research Award of Anaesthesia

  • China Distinguishable Anaesthetist Award

  • Wu Yang Medical Medicine Award

  • Nie Jiedong Medical Award

  • Health Defender of Healthy China

  • Top 10 Innovative Medical Experts

These accolades underscore his unparalleled contributions to the advancement of medical science and patient care.

📑NOTABLE PUBLICATIONS

"The UCP2/PINK1/LC3b-mediated mitophagy is involved in the protection of NRG1 against myocardial ischemia/reperfusion injury" 

  • Authors: X., Li, Xintao , X., Li, Xinyue , T., Tian, Tian , M., Jin, Mu , F., Xue, Fushan
  • Journal: Redox Biology
  • Year: 2025

"Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy" 

  • Authors: Y., Gao, Ying , L., Li, Lu , F., Zhao, Fang , M., Jin, Mu , F., Xue, Fushan
  • Journal: Drug Design, Development and Therapy
  • Year: 2025

"Subglottic airway injury during fiberscope-monitored intubation with a supraglottic airway device: A randomized controlled comparison of three tracheal tubes" 

  • Authors: K., Su, Kai , S., Xu, Shangjun , H., Wang, Haixia , F., Xue, Fushan , M., Tian
  • Journal: Ming Chinese Medical Journal
  • Year: 2025

Dangdang Wang | Glaucoma | Best Researcher Award

Posted on by Pencis

Mr. Dangdang Wang | Glaucoma | Best Researcher Award

The First Affiliated Hospital of Chongqing Medical University | China

Author Profile

Scopus

Orcid ID

Google Scholar

👁️‍🗨️ DANGDANG WANG — EMERGING VISION‑SCIENCE SCHOLAR

🎓 EARLY ACADEMIC PURSUITS

Dangdang Wang completed a Bachelor of Medicine (Sept 2023) at The First Clinical College of Chongqing Medical University. While still an undergraduate, he gravitated toward immune‑related disorders, setting the stage for a career studying how dysregulated immunity damages ocular tissues. His capstone projects and lab rotations introduced him to experimental glaucoma models, sparking a passion for translational eye research.

🏥 PROFESSIONAL ENDEAVORS

  • Postgraduate Student (2023 – present), Department of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University

    • Pursues an M.Sc. in Ophthalmology (expected June 2026) under Prof. Hong Li.

    • Embedded in the Chongqing Key Laboratory for the Prevention and Treatment of Major Blinding Eye Diseases and the National Clinical Research Center for Ocular Diseases (Chongqing Branch), gaining access to cutting‑edge imaging, single‑cell omics, and biostatistics cores.

  • Active collaborator with neurologists, immunologists, and bioinformaticians to build multi‑omic datasets that decode optic‑nerve degeneration.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON GLAUCOMA

GLAUCOMA PATHOGENESIS THROUGH FOUR LENSES:

  1. IMMUNITY – Profiling resident and infiltrating immune cells in glaucomatous optic nerves to map cytokine networks.

  2. INFLAMMATION – Identifying inflammasome activation patterns that tip the balance from neuroprotection to neurodegeneration.

  3. GENETIC SUSCEPTIBILITY – Mining GWAS and family cohorts to pinpoint risk alleles in complement and metabolic genes.

  4. METABOLIC DYSFUNCTION – Linking retinal‑ganglion‑cell energy failure to systemic metabolic shifts.

Notable early outputs: a conference abstract on NLRP3‑inflammasome blockade restoring axonal transport in rat glaucoma models, and a first‑author review (in press) summarizing immunometabolic crosstalk in optic‑nerve injury.

🌍 IMPACT AND INFLUENCE

Although still in training, Wang’s interdisciplinary approach is already:

  • Bridging clinical and basic science by integrating patient‑derived aqueous‑humor proteomics with animal‑model data.

  • Guiding therapeutic pipelines—his findings on metabolic rescue pathways are informing small‑molecule screening projects at the Chongqing Eye Institute.

  • Mentoring peers in statistics workshops, boosting lab‑wide reproducibility standards.

📊 ACADEMIC CITES

  • >15 citations to date across two co‑authored papers on ocular immunology (Scopus, April 2025).

  • Invited speaker at the 2024 China Young Ophthalmologist Forum, where his talk on “Metabolomics‑Driven Targets for Neuroprotection” was highlighted by session chairs.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

By combining immune phenotyping, metabolomics, and precision genetics, Dangdang Wang aims to:

  1. Define a unified “immune‑metabolic glaucoma signature” to stratify patients for personalized therapy.

  2. Translate bench insights to bedside trials, advancing neuroprotective agents that modulate both inflammation and energy metabolism.

  3. Champion open‑data initiatives within Chinese ophthalmology, accelerating nationwide collaboration.

With strong methodological skills (SPSS, R, single‑cell RNA‑seq pipelines) and a collaborative mindset, Wang is poised to become a next‑generation leader in vision science, reshaping how glaucoma is understood and treated. 🔭

📑NOTABLE PUBLICATIONS

"Potential Functions and Causal Associations of GNLY in Primary Open-Angle Glaucoma: Integration of Blood-Derived Proteome, Transcriptome, and Experimental Verification" 

  • Authors: D., Wang, Dangdang , Y., Pu, Yanyu , X., Gao, Xi , L., Zeng, Lihong , H., Li, Hong
  • Journal: Journal of Inflammation Research
  • Year: 2025

Dr. Nana Jin | Hearing loss | Best Researcher Award

Posted on by Pencis

Dr. Nana Jin | Hearing loss | Best Researcher Award

Institute for Translational Neuroscience of Affiliated Hospital 2 of Nantong University | China

Author Profile

Scopus

Orcid ID

🧠 NANA JIN: PIONEER IN TRANSLATIONAL NEUROSCIENCE

🎓 EARLY ACADEMIC PURSUITS

Nana Jin was born on March 21, 1986, in Anyang, Henan, China. Her academic journey began with a strong foundation in the life sciences. She earned her Bachelor of Science from the Life Science College of Henan Normal University in 2007. Driven by a passion for neuroscience, she pursued a Master of Science at the Key Laboratory of Neuroregeneration of Nantong University, where she honed her research skills and built the groundwork for her future contributions. She later achieved her Ph.D. in Medicine from the Medical School of Nantong University in 2022, deepening her expertise in neurodegenerative diseases.

🧪 PROFESSIONAL ENDEAVORS

Nana Jin's professional career spans over a decade of dedication to neurological research. She began as a junior researcher (2010–2014) at the Key Laboratory of Neuroregeneration, where she contributed to vital studies on neuronal repair. She was promoted to Assistant Researcher in 2014 and continued her work there until 2023.

In 2023, she transitioned to the Institute for Translational Neuroscience at the Affiliated Hospital 2 of Nantong University, where she initially served as an Assistant Researcher. Later that year, she was elevated to the role of Associate Researcher, reflecting her growing impact and leadership in the field.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON HEARING LOSS

Nana Jin's research centers on neurodegeneration, particularly the molecular mechanisms underlying tau pathology in Alzheimer’s disease and related disorders. Her investigative focus includes:

  • The inhibition of tau propagation under cerebral hypoperfusion.

  • The interplay between GSK3β and PP2A methyltransferase.

  • The role of TDP-43 and its cross-pathological associations with tau.

  • Targeted monoclonal antibody therapies against tau protein.

Her research also extends to diabetes-related gene function and kinase regulation in neurodegenerative contexts.

🌍 IMPACT AND INFLUENCE

Dr. Jin has played critical roles in several national-level research projects, both as Principal Investigator and as a key participant. Her work contributes significantly to our understanding of Alzheimer’s disease, and she has been part of innovative strategies for early intervention and therapeutic targeting. Her team’s achievements have laid the groundwork for clinical applications aimed at halting or reversing pathological brain changes.

📊 ACADEMIC CITES AND PROJECT FUNDING

Nana Jin’s work has been supported by prestigious grants such as:

  • National Natural Science Foundation General and Youth Projects.

  • Jiangsu Provincial Natural Science Foundation.

  • High-Level Talent Introduction Project.

She has been awarded over 4 million RMB in competitive research funding, demonstrating both the trust of the scientific community and the value of her contributions. Her published findings are frequently cited in the neurodegeneration research field, contributing to the global body of knowledge.

🏆 AWARDS AND HONOURS

Nana Jin's scientific excellence has earned her multiple accolades:

  • 🥇 2018 Jiangsu Provincial Government Scholarship for Overseas Study

  • 🏅 2015 Natural Science Award (Second Prize) from the Ministry of Education for her work on tau protein metabolism

  • 👩‍🔬 2015 Outstanding Scientific Innovation Team recognition from Jiangsu Higher Education Institutions

These honors reflect her recognized role in advancing neuroscience both in China and internationally.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Jin is poised to continue her trailblazing work in translational neuroscience, particularly in the prevention and treatment of Alzheimer’s disease. With her strong academic background, extensive research experience, and continued support from key institutions, she is expected to contribute significantly to future breakthroughs in neurodegenerative disease therapy and molecular brain research.

📑NOTABLE PUBLICATIONS

"Genome-wide profiling and functional characterization of circular RNAs in neural development and injury: insights from a rat model research" 

  • Authors: J., Yang, Jian , N., Jin, Nana , S., Zhang, Shuqiang, Z., Cui, Zhiming , L., Xu, Lian
  • Journal: Cellular and Molecular Life Sciences
  • Year: 2025

"Integrative mRNA and miRNA Expression Profiles from Developing Zebrafish Head Highlight Brain-Preference Genes and Regulatory Networks " 

  • Authors: S., Zhang, Shuqiang , J., Yang, Jian , J., Xu, Jie , N., Jin, Nana , X., Li, Xiaoyu
  • Journal: Molecular Neurobiology
  • Year: 2025

"From microsphere synthesis to neural tissue regeneration: Unraveling the potentials and progress" 

  • Authors: Y., Liu, Yaqiong , Y., Shang, Yuqing , Z., Wang, Zhen , Y., Yang, Yumin , G., Li, Guicai

Xinyu Hu | Medical Education | Speaker

Posted on by Pencis

Dr. Xinyu Hu | Medical Education | Speaker

Huazhong University of Science and Technology | China

Author Profile

Scopus

Orcid ID

👩‍⚕️ DR. XINYU HU: A CHANGEMAKER IN MEDICAL EDUCATION AND GENOMIC RESEARCH

EARLY ACADEMIC PURSUITS 🎓

Dr. Xinyu Hu began her academic journey at Tongji Medical College of Huazhong University of Science and Technology, one of China's most prestigious institutions for medical education. Her foundational training in medicine laid the groundwork for a career that would merge clinical neurology, educational reform, and genomic research. Early exposure to innovative methodologies and cross-disciplinary studies sparked her interest in problem-based learning (PBL) and its role in shaping future generations of healthcare professionals.

PROFESSIONAL ENDEAVORS 💼

Dr. Hu is based in the Department of Neurology at Union Hospital, affiliated with Tongji Medical College, Huazhong University of Science and Technology in Wuhan, China. She has collaborated with numerous departments across different institutions, including cardiology, ophthalmology, and pediatrics, demonstrating a holistic and interdisciplinary approach to medical science. Her collaborative network extends internationally, with research ties to the Laboratory of Psychiatric Neurogenomics at McLean Hospital, Harvard Medical School.

CONTRIBUTIONS AND RESEARCH FOCUS ON MEDICAL EDUCATION🔬

Dr. Xinyu Hu has made meaningful contributions in two major domains:

1. MEDICAL EDUCATION INNOVATION

She is a co-author of the highly relevant study titled:
“Medical Education Challenges in Mainland China: On Application of Problem-Based Learning”
This work critically explores how PBL can address systemic challenges within China's traditional medical training systems. She highlights both the benefits and limitations of implementing this student-centered approach in mainland China's academic culture.

2. GENOMIC SCIENCE

Her interest in the Human Genome Project and its implications signifies her commitment to integrating cutting-edge genomic knowledge into clinical and educational settings, making her a forward-thinking figure in the emerging field of personalized medicine.

IMPACT AND INFLUENCE 🌍

Dr. Hu's work has had a far-reaching impact on how educators and policymakers view medical training in China. Her publications emphasize progressive teaching models and encourage educational reform to keep pace with global trends. Her collaborative efforts with international institutions highlight her global perspective, which is rare and valuable in localized medical education contexts.

ACADEMIC CITES AND RECOGNITION 📚

While her citation metrics are emerging, Dr. Hu’s work is gaining recognition in academic circles for addressing practical challenges in real-world medical education. Her multi-authored publications with diverse affiliations reflect the trust and respect she has earned within the academic community.

LEGACY AND FUTURE CONTRIBUTIONS 🌱

Dr. Xinyu Hu is on track to become a leading voice in medical education reform in China. By linking neurology, genomics, and pedagogical theory, her work sets the stage for an educational model that is both scientifically rigorous and pedagogically sound.

FUTURE OUTLOOK📘

  • Expansion of PBL frameworks across medical universities in China

  • Further exploration into how genomic knowledge can be woven into medical curricula

  • Mentorship of young medical educators and researchers

  • Strengthening international collaborations for cross-border innovation in healthcare education

NOTABLE PUBLICATIONS📑

"Human-in-the-loop machine learning-based quantitative assessment of hemifacial spasm based on volumetric interpolated breath-hold examination" 

  • Authors: MR Z., Huang, Zengan , X., Wang, Xinyi , X., Liu, Xiaoming , N., Xiong, Nian , Y., Gao, Yi
  • Journal: British Journal of Radiology
  • Year: 2025